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C E L L  B I O L O G Y
Osteoprotegerin reduces osteoclast resorption activity 
without affecting osteogenesis on nanoparticulate 
mineralized collagen scaffolds
Xiaoyan Ren1,2,3, Qi Zhou1,2,3, David Foulad1,2,3, Aleczandria S. Tiffany4, Marley J. Dewey5, 
David Bischoff2, Timothy A. Miller1,2, Russell R. Reid6, Tong-Chuan He7, Dean T. Yamaguchi2, 
Brendan A. C. Harley4,8, Justine C. Lee1,2,3*
The instructive capabilities of extracellular matrix–inspired materials for osteoprogenitor differentiation have 
sparked interest in understanding modulation of other cell types within the bone regenerative microenvironment. 
We previously demonstrated that nanoparticulate mineralized collagen glycosaminoglycan (MC-GAG) scaffolds 
efficiently induced osteoprogenitor differentiation and bone healing. In this work, we combined adenovirus- 
mediated delivery of osteoprotegerin (AdOPG), an endogenous anti-osteoclastogenic decoy receptor, in primary 
human mesenchymal stem cells (hMSCs) with MC-GAG to understand the role of osteoclast inactivation in 
augmentation of bone regeneration. Simultaneous differentiation of osteoprogenitors on MC-GAG and osteoclast 
progenitors resulted in bidirectional positive regulation. AdOPG expression did not affect osteogenic differentiation 
alone. In the presence of both cell types, AdOPG-transduced hMSCs on MC-GAG diminished osteoclast-mediated 
resorption in direct contact; however, osteoclast-mediated augmentation of osteogenic differentiation was 
unaffected. Thus, the combination of OPG with MC-GAG may represent a method for uncoupling osteogenic 
and osteoclastogenic differentiation to augment bone regeneration.
INTRODUCTION
Materials inspired by bone-specific extracellular matrix (ECM) 
components have generated great enthusiasm in regenerative tech-
nologies because of their abilities to instruct osteoprogenitor differ-
entiation. In addition, recent attention to the effects on osteoclast 
activation has suggested the potential for modulation of resorption 
within the host microenvironment via alterations of the receptor 
activator of nuclear factor B (RANK), RANK ligand (RANKL), 
and osteoprotegerin (OPG) axis (1).
The RANK/RANKL/OPG axis serves an important role in osteo-
clast regulation and bone homeostasis (1, 2). The activation of RANK, 
a tumor necrosis factor superfamily receptor originally identified in 
T lymphocytes and osteoblasts, via its cognate ligand RANKL is re-
quired for osteoclast differentiation and activation (3, 4). Murine 
genetic models have shown that both RANK and RANKL deficiencies 
resulted in osteopetrosis because of a complete absence of osteo-
clasts (5, 6). In the craniofacial skeleton, RNA interference using 
small interfering RNAs (siRNAs) specific for RANK has been 
shown to fuse patent cranial sutures in ex vivo cultures (2). OPG, the 
soluble decoy receptor for RANKL, is the major endogenous negative 
regulator of the pathway. In contrast to the RANK- and RANKL- 
deficient mice, OPG knockouts exhibit profound osteoporosis (6, 7). 
Because of the direct relationship between the RANK/RANKL/OPG 
axis and osteoclast activation, targeted therapies against the axis are 
under investigation for fracture healing and other conditions re-
quiring a net osteogenic state (8). Similar to other immune cells such as 
lymphocytes, in vivo activation of osteoclasts proceeds with two signals. 
While the RANK/RANKL/OPG axis is undeniably the major signal, 
co-stimulation via receptors such as osteoclast-associated receptor 
(OSCAR) contributes to homeostasis and may be deranged in patho-
logic circumstances (9, 10).
The importance of osteoclast homeostasis in normal bone phys-
iology suggests that bone regeneration is likely to be affected by the 
regulatory mechanisms of osteoclast activity. Components of ECM-
based materials have been reported to both affect osteogenic differ-
entiation and negatively or positively regulate osteoclastogenesis 
(11). As the most abundant protein within bone ECM, most ECM- 
inspired materials for bone regeneration are based on collagen I 
(11). However, the ligands for OSCAR, a costimulatory molecule 
for osteoclast maturation, are collagens I, II, and III (9). Thus, 
collagen- based materials intrinsically provide costimulation for 
osteoclast activation, potentially lowering the threshold for resorp-
tion. Collagen-based osteoclast costimulation is likely able to be offset 
with the negative osteoclast regulatory effects of certain glycosami-
noglycan (GAG) species, as well as the inorganic components of 
bone ECM. Salbach-Hirsch and colleagues (12) extensively evaluated 
sulfated GAG (sGAG) coatings and found an increased osteogenic 
differentiation of primary murine mesenchymal stem cells and 
simultaneously diminished osteoclast activity, in part through se-
questration of OPG. The mechanism for which GAGs or sGAGs 
influence osteoclastogenesis remains to be elucidated, although 
their work suggested that sulfation status may differentially affect 
osteoclast activity. Inorganic ions, specifically calcium and phosphate, 
have been the most extensively described ECM components that 
contribute to osteoclast action. High levels of extracellular calcium 
ions, such as during bone remodeling, negatively regulate podosomal 
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assembly and resorption via entry through the L-type voltage–gated 
calcium channels (13). Similarly, high levels of extracellular inor-
ganic phosphate inhibit RANKL-induced osteoclast activity in a 
manner dependent on the sodium phosphate cotransporter (14). 
Recently, the signaling mechanisms induced by inorganic ions in 
the context of materials have been characterized in greater detail, 
and further modulation may be of great utility in regenerative tech-
nologies (15, 16). Using a combination biphasic silicified and calci-
fied collagen material, Jiao et al. (17) demonstrated the up-regulation 
of OPG gene expression during osteogenic differentiation that was 
not present to the same degree in monophasic silicified collagen 
scaffolds or calcified collagen scaffolds. Signaling pathways respon-
sible for osteogenesis and osteoclast inhibition of the biphasic silicified 
and calcified collagen material were regulated by different intracellular 
mediators.
Our group previously demonstrated that a nanoparticulate min-
eralized collagen glycosaminoglycan (MC-GAG) scaffold induced 
efficient mineralization of bone marrow–derived primary human 
mesenchymal stem cells (hMSCs) and primary rabbit bone marrow 
stromal cells via autogenous activation of the bone morphogenetic 
protein receptor (BMPR) signaling pathway through phosphorylation 
of small mothers against decapentaplegic-1/5 (p-Smad1/5) (18–22). 
Furthermore, we demonstrated that MC-GAG scaffold induced in 
vivo rabbit calvarial regeneration without the addition of exoge-
nous growth factors or progenitor cells (21). We recently reported 
that MC-GAG scaffold demonstrated both direct and indirect in-
hibitory effects on osteoclast viability, proliferation, and activation 
(23). In comparison to its nonmineralized collagen glycosamino-
glycan (Col-GAG) scaffold counterpart, MC-GAG scaffolds directly 
reduced viability and proliferation of primary osteoclast precursors. 
MC-GAG scaffolds also induced hMSCs to express higher levels of 
OPG during osteogenic differentiation via intracellular signaling 
pathways distinct from those governing osteogenic differentiation. 
Combining these findings suggests two concepts: (i) ECM-based 
materials for skeletal regeneration must account for both osteogenesis 
and osteoclastogenesis and (ii) differences in regulatory mechanisms 
evoked by nonmineralized versus mineralized collagen scaffolds may 
provide a route to disconnect physiologic osteoblast and osteoclast 
coupling. In this work, we evaluate the addition of an adenovirus- 
mediated OPG (AdOPG) expression in primary hMSCs with MC-GAG 
scaffolds to promote osteogenesis and augment osteoclast inhibition.
RESULTS
AdOPG transduction of primary hMSCs differentiated on 
Col-GAG and MC-GAG does not affect cell viability  
or proliferation
Recently, we reported that MC-GAG induces hMSCs to up-regulate 
OPG at higher levels than Col-GAG, suggesting a potential role for 
MC-GAG in simultaneously regulating the host resorptive capacity 
in the local microenvironment during bone regeneration. However, 
the amount of OPG protein expressed by hMSCs differentiated on 
MC-GAG was only significantly higher within the first 10 days of 
differentiation. Thus, we hypothesized that a prolongation of OPG 
expression may augment the antiresorptive capabilities of MC-GAG.
In an effort to augment anti-osteoclastogenic activities induced 
by MC-GAG, primary bone marrow–derived hMSCs (CD105+CD166+ 
CD29+CD44+CD14−CD34−CD45−) were transduced with AdOPG. 
Control and AdOPG-transduced hMSCs were cultured in osteogenic 
differentiation medium for 7 and 14 days and evaluated for infec-
tion efficiency, OPG expression, and effects on cell viability and 
proliferation (Fig. 1). Using the coexpressed red fluorescent protein 
(RFP) as an indicator, AdOPG transduction resulted in a 35% infec-
tion efficiency based on cell counting with a maximum amount of 
protein expression on Western blot analysis at a multiplicity of infection 
(MOI) of 200 (Fig. 1B).
Before evaluating long-term scaffold mineralization, the viability 
and proliferation of hMSCs were confirmed by measuring the mito-
chondrial dehydrogenase activity using the WST-1 (water-soluble 
tetrazolium salt 1) colorimetric assay. hMSC viability and proliferation 
were not found to be significantly different in control versus 
AdOPG-infected cells in two-dimensional (2D) cultures after 3 weeks 
of transduction (Fig. 1C). To confirm that cells were viable in long-
term 3D cultures, we seeded control and AdOPG on Col-GAG and 
MC-GAG and differentiated them for 8 weeks in osteogenic differ-
entiation medium (Fig. 1D). Again, hMSC cell viability and prolif-
eration were found to be equivalent between control and AdOPG 
hMSCs on Col-GAG or MC-GAG with no statistically significant 
differences between the materials.
AdOPG transduction changes RANKL/OPG homeostasis in 
primary hMSCs differentiated on Col-GAG and MC-GAG
Because of the known importance of the OPG to RANKL-relative 
protein ratios in influencing bone homeostasis, we next evaluated 
the relative expression of OPG to RANKL in control and AdOPG- 
infected cells. Control and AdOPG-infected cells were induced to 
undergo osteogenic differentiation on Col-GAG and MC-GAG for 
14 days, and quantitative real-time reverse transcription polymerase 
chain reaction (qRT-PCR) was performed to assess OPG and RANKL 
gene expression (Fig. 2, A and B). No statistically significant differ-
ences were found in OPG or RANKL gene expression between control 
cells on either material. In the presence of AdOPG, OPG gene ex-
pression increased more than 30-fold in cells cultured on either scaffold, 
while no differences in RANKL expression was noted.
Protein expression was next evaluated using both Western blot 
and enzyme-linked immunosorbent assay (ELISA) of OPG and RANKL 
expression over 56 days (Fig. 2, C to F). On Western blot analysis, 
we detected two dominant isoforms of RANKL including a band at 
35 kDa, as well as a higher–molecular weight band near 45 kDa, 
which may reflect expression of different splice variants, similar to 
reports by several other investigators (24, 25). Densitometry was 
used to quantify the relative expression of OPG and RANKL, and 
the RANKL/OPG protein expression ratio over 56 days was evalu-
ated (Fig. 2E). As Western blots were performed on the total protein 
of the scaffolds, the RANKL/OPG ratio derived represented the total 
cellular and scaffold-bound protein. A statistically significant dif-
ference was found in the RANKL/OPG protein expression ratios 
between the groups [F(3,24) = 19.35, P < 0.001]. In both Col-GAG 
and MC-GAG, AdOPG expression lowered the RANKL/OPG pro-
tein expression ratio as expected (P < 0.001). In control hMSCs, 
Col-GAG displayed a higher RANKL/OPG ratio compared to MC-
GAG (P < 0.001).
In addition to scaffold-bound protein, we evaluated RANKL and 
OPG in culture supernatants using ELISAs to calculate the secreted 
RANKL/OPG ratio (Fig. 2F). Similar to total protein RANKL/OPG 
ratios, a statistically significant difference was found [F(3,20) = 60.56, 
P < 0.001]. Unlike the total protein of the scaffolds, the secreted 
RANKL/OPG ratio was higher in MC-GAG compared to Col-GAG 
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(P < 0.001) in control cells. Expression of AdOPG diminished the 
RANKL/OPG ratio compared to control cells on MC-GAG (P < 0.001), 
whereas less of an effect was observed for Col-GAG. Together, 
AdOPG significantly reduces the RANKL/OPG ratio at both the 
levels of gene and protein expression. For the alterations in RANK/
OPG protein ratios, the difference is primarily manifested in cellular 
or scaffold-bound protein rather than secreted protein.
AdOPG does not affect hMSC mineralization on Col-GAG  
or MC-GAG
Two reports have suggested that OPG may have capabilities to 
induce osteogenic differentiation and mineralization in osteopro-
genitor cells separate from its effects on osteoclasts and osteoclast 
precursors (26, 27). To evaluate whether AdOPG directly affects 
mineralization in our system, we evaluated control and AdOPG- 
infected hMSCs undergoing osteogenic differentiation on Col-GAG 
and MC-GAG for expression of osteogenic markers, activation of 
osteogenic signaling pathways, and matrix mineralization (Fig. 3). 
At 14 days of culture, no significant differences in runt-related tran-
scription factor 2 (RUNX2) or osteopontin (OPN) gene expression 
were found between control and AdOPG cells on Col-GAG or MC-GAG 
(Fig. 3, A and B).
We previously showed that both Col-GAG and MC-GAG de-
pended on the activation of the BMPR signaling pathway via 
p-Smad1/5 for osteogenic differentiation and matrix mineralization 
(22). Thus, to evaluate the contribution of AdOPG to the activation 
of intracellular signaling pathways that contribute to mineralization 
on Col-GAG and MC-GAG, we performed the Western blots analyses 
of control and AdOPG-infected hMSCs undergoing osteogenic dif-
ferentiation on Col-GAG or MC-GAG on total protein lysates over 
8 weeks (Fig. 3, C and D). No significant differences in p-Smad1/5 
activation were detected in the absence or presence of AdOPG. MC-GAG, 
as we previously demonstrated, induced substantially more p-Smad1/5 
compared to Col-GAG.
We also quantified matrix mineralization using microcomputed 
tomography (CT) analysis (Fig. 3, E and F). Again, no significant 
differences between control and AdOPG hMSCs were detected on 
either Col-GAG or MC-GAG. Similar to our previous reports, MC-GAG 
demonstrated more mineralization than Col-GAG with or without 
AdOPG.
Indirect osteoclast cocultures augment mineralization in 
hMSCs undergoing mineralization on MC-GAG in the 
absence or presence of AdOPG
To understand the effects of MC-GAG on human osteoclasts (hOCs), 
we used two coculture techniques: indirect and direct. Indirect co-
cultures were performed to isolate the effects of hOCs on hMSCs 
and vice versa without the confounding effects of scaffold resorp-
tion from direct contact and to understand the paracrine effects 
between the two cell types (Fig. 4A). Direct cocultures were de-
vised for the purposes of understanding the net effects of the system 
with cells and materials in direct contact with each other. For indi-
rect cocultures, Col-GAG or MC-GAG scaffolds were cultured in 
an 8-m Transwell insert with and without hMSCs seeded on the 
materials (upper chamber). In the lower chamber, human primary 
pre-osteoclasts were seeded on a calcium phosphate–coated plate 
A
C
B
D
Fig. 1. AdOPG transduction of primary hMSCs differentiated on Col-GAG and MC-GAG does not affect cell viability or proliferation. (A) Photomicrograph of 
AdOPG-transduced primary hMSCs in 2D cultures after 7 days. (B) Western blot of primary hMSCs transduced with control or AdOPG viruses for 7 days on 2D cultures at 
varying MOI. (C and D) WST-1 proliferation and viability assays of primary hMSCs transduced with control of AdOPG viruses at (C) 3 weeks in 2D cultures and (D) 8 weeks 
on Col-GAG or MC-GAG. Mean values are shown in bars, with error bars representing SD.
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where resorptive activity may be evaluated. Cocultures were con-
currently differentiated with medium supplemented with RANKL, 
macrophage colony-stimulating factor (M-CSF), -glycerophosphate, 
ascorbic acid, and dexamethasone.
In the indirect coculture system, the effects on hMSCs were first 
evaluated. After 21 days of culture, we subjected the Transwell in-
serts (upper chambers) to WST-1 assay (Fig. 4B). Statistically signifi-
cant differences in viability and proliferation were found between 
hMSCs of the different groups [F(7,18) = 81.36, P < 0.001]. Empty 
Col-GAG or MC-GAG scaffolds without hMSCs cocultured with 
osteoclasts displayed no evidence of cell viability or proliferation as 
expected (P < 0.001 compared to any other conditions). No differ-
ences were found between hMSCs cultured without osteoclasts (hMSC 
only) or control hMSCs cocultured with osteoclasts (control hMSC/OC) 
on either material. With AdOPG, hMSCs cultured on MC-GAG 
demonstrated a decrease in viability and proliferation compared to 
Col-GAG in a statistically significant fashion (P = 0.03).
To determine the amount of soluble OPG in the coculture sys-
tem, we performed ELISAs over the entirety of the coculture period 
and compared them to an osteoclast-only negative control (Fig. 4C). 
Differences between the cultures were found to be statistically sig-
nificant [F(4,15) = 552.37, P < 0.001]. Osteoclasts did not display 
any significant amount of OPG secretion as expected. In control 
cells, hMSCs on MC-GAG produced significantly more endoge-
nous OPG compared to Col-GAG at day 7 (P < 0.001) and day 10 
(P = 0.02). Multiple comparisons of any control time point versus 
any AdOPG-infected time point for either material displayed sig-
nificantly higher amounts of OPG in AdOPG-infected cells (P < 0.001 
for all conditions).
We evaluated mineralization after 3 weeks of coculture using 
CT scanning (Fig. 4, D and E). Overall, differences in mineralization 
were found to be present [F(7,26) = 26.48, P < 0.001]. An increase in 
osteogenic differentiation occurred in control hMSC cocultures with 
differentiating hOCs (control hMSC/OC) compared to hMSC single 
cultures (hMSC only) on MC-GAG materials (P < 0.001). Although 
a mild increase in mineralization was evident qualitatively and 
quantitatively on Col-GAG in cocultures versus single cultures, this 
difference did not reach statistical significance. In MC-GAG, the 
increase in mineralization for cocultures with AdOPG compared to 
hMSC-only single cultures remained significant (P = 0.02). In com-
bination, indirect cocultures of differentiating hMSCs with hOCs 
resulted in positive regulation of osteogenic differentiation mani-
fested by mineralization, particularly on MC-GAG. This increase in 
mineralization is largely unaffected by AdOPG transduction.
Indirect cocultures with AdOPG-transduced hMSCs on 
MC-GAG diminish hOC resorptive activity
In the same indirect cocultures, we also evaluated the effects on os-
teoclasts (Fig. 4, F and G). Following removal of the Transwell in-
serts, the lower chamber consisting of hOCs was subjected to WST-1 
assay and found to have statistically significant differences on analysis 
of variance (ANOVA) [F(6,21) = 9.23, P < 0.001]. An increase in 
A C E
B D F
Fig. 2. AdOPG transduction changes RANKL/OPG homeostasis in primary hMSCs differentiated on Col-GAG and MC-GAG. qRT-PCR of control or AdOPG-transduced 
primary hMSCs cultured on Col-GAG or MC-GAG materials for 14 days in osteogenic differentiation medium for (A) OPG and (B) RANKL (n = 3). Western blot of (C) control 
or (D) AdOPG-transduced primary hMSCs cultured on Col-GAG or MC-GAG materials for 56 days in osteogenic differentiation medium for RANKL, OPG, and -actin. Average 
RANKL/OPG protein expression ratio based on (E) densitometric analysis of RANKL and OPG Western blot bands or (F) ELISA of culture supernatants over 8 weeks. Mean 
values are shown in bars, with error bars representing SD. Significant post hoc comparisons following analysis of variance (ANOVA) indicated with P values.
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viability and proliferation or hOCs occurred in cocultures with control 
hMSCs on Col-GAG or MC-GAG (P = 0.02 and P < 0.001, respectively). 
AdOPG-transduced hMSCs diminished viability and proliferation 
of hOCs compared to control hMSCs on MC-GAG (P = 0.03). Minimal 
differences in hOC viability were detected on Col-GAG with hMSCs 
transduced with AdOPG.
Resorptive activity of the hOCs was also characterized and found to 
have significant differences via ANOVA [F(6,17) = 15.34, P < 0.001; 
Fig. 4G]. hOC-mediated resorption significantly increased in cocul-
tures of hMSCs on Col-GAG (P = 0.001) or MC-GAG (P = 0.002) 
compared to hOC single cultures. In AdOPG-transduced hMSCs, 
hOC-mediated resorption diminished on both materials compared 
to control hMSCs; however, only the decrease in MC-GAG reached 
statistical significance (P < 0.001). In combination, these data suggest 
that differentiating hMSCs increase the viability, proliferation, and 
resorptive capabilities of hOCs on either nonmineralized or mineralized 
Col-GAG materials. While cocultures with AdOPG- transduced 
hMSCs mildly reduced hOC viability, proliferation, and resorption 
on Col-GAG, MC-GAG demonstrated a significantly greater effect.
Direct contact of AdOPG-transduced hMSCs on Col-GAG and 
MC-GAG with osteoclasts diminishes the proliferation and 
resorption activity of osteoclasts
Next, the effects on osteoclasts were evaluated in a direct coculture 
system. hOCs were first plated on a calcium phosphate–coated plate. 
Two hours after seeding, hMSCs seeded on Col-GAG or MC-GAG 
were transferred to each well in direct contact with hOCs. Cocul-
tures were simultaneously differentiated with medium supplemented 
with RANKL, M-CSF, -glycerophosphate, ascorbic acid, and dexa-
methasone. After 14 days of culture, we removed the respective 
scaffolds and subjected the osteoclasts to WST-1 assay (Fig. 5A). 
Statistically significant differences between the cultures were noted 
[F(6,14) = 22.48, P < 0.001]. In the presence of empty Col-GAG, the 
viability and proliferation were not significantly different from 
osteoclasts differentiated alone (OC only). As we previously reported, 
empty MC-GAG materials did reduce osteoclast viability and pro-
liferation (23). Between control versus AdOPG-transduced hMSCs 
on either material, both viability and proliferation were diminished 
in the presence of AdOPG.
We assessed osteoclast differentiation and activity using tartrate- 
resistant acid phosphatase (TRAP) staining and resorption pit 
assays, respectively (Fig. 5, B and C). Under all conditions, with the 
exception of the negative control, TRAP activity was detected, indi-
cating that osteoclasts were present. Osteoclast activity, detected by 
resorption pits of the inorganic crystalline calcium phosphate coat-
ing of the plate, demonstrated significant differences between the 
groups. In the presence of empty Col-GAG, a mild decrease in 
resorption was elicited, which was rescued with the addition of con-
trol hMSCs. In MC-GAG, a significant decrease in resorptive abili-
ties was seen, which was also improved with the addition of control 
hMSCs. In both cases, osteoclast resorption was completely inhibited 
when transduced with AdOPG.
Quantification of the total resorption pit areas demonstrated 
significant differences in resorption activity between the conditions 
A B C
E F D
Fig. 3. AdOPG does not affect hMSC mineralization on Col-GAG or MC-GAG. qRT-PCR of control or AdOPG-transduced primary hMSCs cultured on Col-GAG or MC-GAG 
materials for 14 days in osteogenic differentiation medium for (A) RUNX2 and (B) OPN (n = 3). Western blot of (C) control or (D) AdOPG-transduced primary hMSCs cul-
tured on Col-GAG or MC-GAG materials for 56 days in osteogenic differentiation medium for Smad5 and p-Smad1/5. (E) Representative CT images and (F) quantitative 
analysis of control or AdOPG-transduced primary hMSCs cultured on Col-GAG or MC-GAG for 8 weeks (n = 3). Bars represent means, and error bars represent SD. Signifi-
cant post hoc comparisons following ANOVA indicated with P values.
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A
C
D
F G
E
B
±
Fig. 4. Osteoclast cocultures indirectly augment mineralization in hMSCs undergoing mineralization on MC-GAG. (A) Schematic diagram of coculture design indi-
cating the placement of differentiating hMSCs on Col-GAG or MC-GAG within Transwell insert and lower chamber consisting of primary pre-osteoclasts cultured on a 
plate coated with calcium phosphate to allow for the detection of resorptive pit activity. (B) WST-1 assays of hMSCs in single culture (hMSC only) or cocultured (control 
hMSC/OC and AdOPG hMSC/OC, respectively) on Col-GAG or MC-GAG for 21 days. Empty cell-free scaffolds cocultured with osteoclasts shown for control (empty scaffolds/OC). 
(C) OPG ELISA of hMSC/OC coculture medium (days 3, 7, 10, and 14) with control and AdOPG-transduced hMSCs on Col-GAG and MC-GAG. Differentiated osteoclast- only 
(OC only) culture shown at the left as a control. (D) Representative CT images and (E) quantitative analysis of empty scaffold (empty), hMSCs without osteoclasts (hMSC only), 
control hMSCs cocultured with osteoclasts, or AdOPG-transduced hMSCs cocultured with osteoclasts on Col-GAG or MC-GAG for 21 days. (F) WST-1 assays of primary 
pre-osteoclasts in single culture (OC only), cocultured with empty scaffolds, or cocultured with control or AdOPG-transduced hMSCs (control hMSC and AdOPG hMSC, 
respectively) in medium supplemented with RANKL and M-CSF on Col-GAG or MC-GAG for 14 days. (G) Quantitative analysis of pit assays as the percentage of total area 
of well in differentiated osteoclasts without hMSCs (OC only) and osteoclasts cocultured with Col-GAG and MC-GAG as empty scaffolds, scaffolds with control hMSCs, and 
scaffolds with AdOPG-transduced hMSCs. Significant post hoc comparisons following ANOVA indicated with P values.
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[F(6,14) = 88.22, P < 0.001; Fig. 5C]. In post hoc comparisons, no 
statistically significant differences were seen between osteoclasts 
cultured alone (OC only) and osteoclasts cocultured with empty 
Col-GAG, whereas osteoclasts cultured with empty MC-GAG were 
significantly less active (P < 0.001). In cocultures with control hMSCs 
differentiated on Col-GAG or MC-GAG, resorption increased com-
pared to empty scaffolds (P < 0.001 for both), although the quantity of 
resorption continued to be lower in MC-GAG compared to Col-GAG 
(P = 0.002). In the presence of AdOPG, resorption was completely 
eliminated for either material compared to scaffolds with control 
hMSCs (P < 0.001 for both).
AdOPG transduction augments mineralization and hMSC 
expression of p-Smad1/5, Runx2, and p-ERK1/2 when 
directly contacting osteoclasts
Direct contact of hMSCs differentiated on Col-GAG and MC-GAG 
with hOCs allows for investigation of the net effects of positive and 
negative regulation including resorption on mineralization. Empty 
Col-GAG and MC-GAG scaffolds, scaffolds seeded with control 
hMSCs, or AdOPG-transduced hMSCs were directly cocultured 
with hOCs and concurrently differentiated for 14 days. Scaffolds 
were assessed for mineralization and activation of intracellular me-
diators known to be involved in osteogenic differentiation (Fig. 6).
A C
B
Fig. 5. AdOPG-infected hMSCs on Col-GAG and MC-GAG diminish the proliferation and resorption activity of osteoclasts. (A) WST-1 proliferation and viability 
assays of primary pre-osteoclasts in single culture (OC only), cocultured with empty scaffolds, or cocultured with control or AdOPG-transduced hMSCs (control hMSC and 
AdOPG hMSC, respectively) in medium supplemented with RANKL and M-CSF on Col-GAG or MC-GAG for 14 days. (B) TRAP staining (top row), resorption pits (middle 
row), and live images (bottom row) of negative control without cells (no cells), osteoclast only without hMSCs or scaffolds (OC only), and osteoclasts cocultured with 
Col-GAG or MC-GAG as empty scaffolds (empty scaffold), with control hMSCs (control), or with AdOPG-transduced hMSCs (AdOPG). (C) Quantitative analysis of pit assays as 
percentage of total area of well in differentiated osteoclasts without hMSCs (OC only) and osteoclasts cocultured with Col-GAG and MC-GAG as empty scaffolds, scaffolds 
with control hMSCs, and scaffolds with AdOPG-transduced hMSCs. Significant post hoc comparisons following ANOVA indicated with P values.
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Unlike indirect cocultures, direct cocultures with hOCs resulted in 
a decrease in mineral content on both Col-GAG and MC-GAG with 
control hMSCs when compared to empty scaffolds (Fig. 6, A and B). 
The decrease in mineralization is in concordance with the increase 
in hOC activity (Fig. 5, B and C) seen in the presence of hMSCs, as 
well as the presence of hOCs directly on the scaffolds (fig. S1). When 
hMSCs transduced with AdOPG on Col-GAG and MC-GAG were 
directly cocultured with hOCs, mineralization was significantly im-
proved, resulting in a net osteogenic state.
To compare the osteogenic mechanisms activated in hMSCs in 
the direct coculture system, intracellular mediators known to be 
up-regulated in osteogenic differentiation were evaluated on Western 
blot analysis (Fig. 6C). Unlike single cultures with hMSCs, direct 
cocultures resulted in an up-regulation of p-Smad1/5, p-ERK1/2 
(phosphorylated extracellular regulated kinase 1/2), and Runx2. These 
data suggest that hOCs simultaneously positively regulate hMSC 
osteogenesis while actively resorbing mineralized volumes. These 
activities may be separated using an endogenous secreted decoy 
receptor for RANKL.
DISCUSSION
In this work, we investigated the feasibility of combining OPG with 
a mineralized collagen scaffold for affecting osteogenic differentia-
tion with concurrent osteoclastogenic inhibition. Using an adeno-
viral vector, we demonstrated that OPG expression did not affect 
the viability or proliferation of primary hMSCs and that expression 
could be detected at even 8 weeks following transduction. With re-
spect to endogenous RANKL and OPG, hMSCs in MC-GAG scaf-
folds demonstrated a significantly lower RANKL/OPG cellular and 
scaffold-bound protein expression ratio compared to nonmineral-
ized Col-GAG scaffolds, albeit a higher RANKL/OPG-secreted protein 
ratio. In the presence of AdOPG, the RANKL/OPG cellular and 
scaffold-bound protein expression ratios were significantly lowered 
from baseline. While AdOPG mildly reduced the secreted RANKL/
OPG protein ratio in Col-GAG, AdOPG significantly diminished 
the secreted RANKL/OPG ratio in MC-GAG. Osteogenic differen-
tiation of control versus AdOPG-transduced hMSCs did not show 
significant differences in terms of expression of osteogenic genes, 
p-Smad1/5, or quantitative matrix mineralization in the absence of 
osteoclasts. In the presence of differentiating primary hOCs in indi-
rect cocultures, mineralization was increased beyond hMSC single 
cultures, particularly in hMSCs cultured on MC-GAG scaffolds. 
Augmented mineralization by hOCs persisted even with AdOPG 
transduction in indirect cocultures, suggesting that paracrine effects 
were responsible for the positive regulation. AdOPG transduction 
mildly affected hOC-mediated resorption in the presence of Col-GAG 
in indirect cultures, whereas resorption is significantly reduced in 
the presence of MC-GAG. Upon direct contact of differentiating 
osteoclasts with Col-GAG or MC-GAG materials, resorptive activi-
ties decreased but could be partially rescued with the addition of 
hMSCs. In the same direct cocultures with AdOPG-transduced 
hMSCs, the resorptive activities of osteoclasts were completely ab-
rogated. The decrease in hOC resorptive activity by AdOPG resulted 
in an increase in activation of intracellular osteogenic mediators on 
both Col-GAG and MC-GAG scaffolds. These results suggest several 
conclusions: (i) hMSC osteogenic differentiation on MC-GAG scaf-
folds is largely unaffected by the addition of OPG; (ii) osteoclast and 
hMSCs cocultures positively regulate the activities of each other; 
(iii) OPG is largely sequestered on the scaffold, and thus, anti- 
osteoclastogenic effects are most evident in direct cocultures; and 
(iv) direct osteogenic and osteoclastogenic coupling may be sepa-
rated to augment bone regeneration, where we observe that hMSCs 
on MC-GAG scaffolds combined with OPG augment osteoclast 
activity inhibition.
Two other groups have suggested that bone regeneration with 
OPG is a viable strategy. Su et al. (28) expressed OPG in rabbit peri-
odontal ligament stem cells seeded on -tricalcium phosphate 
materials for regeneration of alveolar defects and demonstrated 
improved bone healing. Liu et al. (29) reported using adeno-
viral expression of OPG in rat BMSCs implanted on hydroxyapatite 
scaffolds for repair of osteoporotic mandible defects. Similar to our 
current report, they reported long-lasting OPG expression, even 
after 6 weeks for their in vivo experiments with a statistically signifi-
cant improvement in mineralization and decrease in osteoclast cell 
density. Our current work now contributes to the concept of OPG 
expression in primary human MSCs and its effect on primary hOC 
differentiation and activity. Our work also demonstrates that the 
expression of OPG does not diminish osteoclast-induced mineral-
ization, suggesting that separate processes within the osteoclast 
control the paracrine stimulation of osteoprogenitors versus the 
resorptive activity of the osteoclast.
In part, the concept of blocking osteoclastogenesis is contrary 
to some of the lessons learned in the genetics literature. In OPG 
knockout mice, a recent study documented that the release of nega-
tive regulation in osteoclastogenesis coincided with a simultaneous 
increase in bone formation, which was mediated through the sup-
pression of sclerostin expression (30). Conversely, Runx2/Cbfa1 
(core-binding factor 1) knockout mouse studies indicated that 
maturational arrest in osteoblast differentiation also resulted in the 
absence of osteoclasts (31, 32). Although this phenomenon was related 
to the expression of RANKL by osteoblasts downstream of Runx2, 
Runx2−/− mice with a soluble RANKL transgene did not result in 
complete rescue (31). The combination of these genetic studies in-
dicates that a direct relationship exists between bone formation and 
resorption. Our current study reflects the positive coordination of 
osteogenic and osteoclastogenic differentiation with observed dual 
increases when both cell types are allowed to interact in coculture 
(Figs. 4 and 5). Thus, it is clear that systemic or permanent deficien-
cies of any of these factors are likely not necessary or useful for bone 
regeneration.
In normal physiology and pathology, there are many examples 
of transient changes in the relative abundance of positive or nega-
tive regulators of osteogenesis or osteoclastogenesis. For osteoclast 
activation and activity, the relative balance between RANKL and 
OPG has been suggested to be responsible for the net effect toward 
bone formation or resorption on the locoregional or organismal en-
vironment (33, 34). In an effort to better understand fracture heal-
ing, Kon et al. (35) evaluated gene expression of the RANK/RANKL/
OPG axis and proinflammatory cytokines in a mouse model. While 
OPG was constitutively expressed, RANKL was up-regulated in re-
sponse to injury. Expressed in a different manner, Tanaka and col-
leagues (36) have demonstrated that the RANKL/OPG ratio changes 
over time following injury with a low ratio in the early stages, favor-
ing bone formation, followed by a higher ratio, favoring bone re-
sorption, later after injury. In our current work, there was a clear 
difference in the total endogenous OPG secreted (Fig. 4C), the 
endogenous RANKL/OPG protein ratio (Fig. 2E), and hOC resorptive 
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activity (Fig. 5C) between control hMSCs cultured in nonmineral-
ized Col-GAG versus MC-GAG scaffolds. The addition of AdOPG 
increases the total quantity of OPG protein and diminishes the total 
cellular and scaffold-bound RANKL/OPG ratio corresponding to 
the decrease in osteoclast resorptive activity in both materials. The 
differences in hOC resorptive abilities between indirect and direct 
cocultures suggest that most of the OPG remain sequestered on the 
scaffold, potentially pointing toward the ability for spatial control of 
modulatory factors in the presence of Col-GAG materials. The 
addition of OPG decreased osteoclast resorption without losing the 
osteogenic effects of hOCs (Fig. 5, D and E). As the osteogenic stim-
ulation of hOCs is evident in indirect cultures, paracrine signals are 
likely the main positive regulatory signals from hOCs.
Despite the bidirectional positive regulation of osteogenic and 
osteoclastogenic differentiation in coculture, the net effects of the 
direct cocultures were tipped toward resorption in the presence of 
endogenous hMSCs (Fig. 6, A and B), suggesting that the endoge-
nous levels of OPG cannot overcome the osteoclast activation present 
in cocultures. In the presence of AdOPG, not only did mineral-
ization improve Smad1/5 phosphorylation and Runx2 protein ex-
pression both increased. As this increase was not detected in single 
cultures of hMSCs transduced with AdOPG, these effects are most 
likely to be attributable to hOC-induced osteogenic effects. Similar 
to the paracrine effects on mineralization, cocultures of AdOPG- 
transduced hMSCs on MC-GAG with hOCs may diminish hOC- 
mediated resorptive capacities but do not mitigate the osteoinductive 
signals from hOCs.
One of the potential benefits of using OPG as a temporary measure 
in decreasing osteoclast activity is that its function is a nonsignaling, 
decoy receptor for the major osteoclast growth factor (1). Although 
we used an adenoviral vector for OPG expression because of its high 
efficiency and high protein production for the purposes of proof of 
concept, a nongenetic method for OPG delivery would likely be better 
suited for clinical translation for safety reasons. In addition, we de-
tected a high level of OPG protein even at 8 weeks following trans-
duction. This may represent a second drawback in using a genetic 
methodology for OPG delivery, as the remodeling phase of bone 
regeneration should be well underway at 8 weeks. Future work on the 
augmentation of osteoclast inhibition on MC-GAG materials would 
likely require refinement of the quantity and timing of OPG release.
In all, controlled coordination of both positive and negative pro-
cesses is essential to the success of regenerative technologies. While 
most of the attention within the bone regeneration field has been 
focused on improving osteogenesis, consideration for diminishing 
osteoclastogenesis has only been recently investigated. Our current 
work details the ability of adenoviral expression of OPG in combina-
tion with MC-GAG to augment the inhibition of osteoclast resorptive 
activity without diminishing the positive paracrine effects on osteo-
genic differentiation. These findings contribute the potential utility 
of a strategy that capitalizes on a transient disturbance in osteoclast 
resorption to allow for the establishment of a critical mass of regen-
erated bone, suggesting new avenues for material development.
MATERIALS AND METHODS
Fabrication and chemical cross-linking of nonmineralized 
and mineralized collagen scaffolds
Col-GAG and MC-GAG scaffolds were prepared using lyophiliza-
tion, as described previously (37–39). Briefly, microfibrillar, type I 
collagen (Collagen Matrix, Oakland, NJ) and chondroitin-6-sulfate 
(Sigma-Aldrich, St. Louis, MO) were combined in suspension in 
the absence and presence of calcium salts (calcium nitrate hydrate, 
Ca(NO3)2·4H2O; calcium hydroxide, Ca(OH)2; Sigma-Aldrich, 
St. Louis, MO) in an acetic acid (Col-GAG) or phosphoric acid 
(MC-GAG) solution. Using a constant cooling rate technique at a 
rate of 1°C/min, the solution was frozen from room temperature to 
−10°C using a freeze dryer (Genesis, VirTis). Following sublimation 
of the ice phase, scaffolds were sterilized via ethylene oxide and cut 
into 8-mm disks in diameter and 4 mm in height for culture.
Cross-linking of scaffolds was performed after rehydration in 
phosphate-buffered saline (PBS) for 4 hours using 1-ethyl-3-(3- 
dimethylaminopropyl)carbodiimide (EDAC; Sigma-Aldrich) and 
N-hydroxysuccinimide (NHS; Sigma-Aldrich) at a molar ratio of 
5:2:1 EDAC:NHS:COOH, where COOH represents the amount of 
A B C
Fig. 6. Direct cocultures of osteoclasts with AdOPG-infected hMSCs on Col-GAG and MC-GAG increase p-Smad1/5, Runx2, p-ERK1/2, and mineralization. 
(A) Representative CT images and (B) quantitative analysis of direct cocultures of osteoclasts with empty scaffold (empty + OC), control hMSCs (hMSC + OC), or 
AdOPG-transduced hMSCs (hMSC/AdOPG + OC) on Col-GAG or MC-GAG for 14 days. Significant post hoc comparisons following ANOVA indicated with P values. 
(C) Western blot of control of AdOPG-transduced primary hMSCs differentiated on Col-GAG or MC-GAG materials cocultured with osteoclasts for 14 days.
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collagen in the scaffold as we previously described (40). Scaffolds 
were washed with PBS to remove any of the residual chemical.
Cell culture
Primary hMSCs (Lonza Inc., Allendale, NJ) were expanded in prolifera-
tion medium composed of Dulbecco’s modified Eagle’s medium (DMEM; 
Corning Cellgro, Manassas, VA) supplemented with 10% fetal bovine 
serum (Atlanta Biologicals, Atlanta, GA), 2 mM l-glutamine (Life 
Technologies, Carlsbad, CA), and penicillin (100 IU/ml)/streptomycin 
(100 g/ml; Life Technologies).
2D culture
hMSCs of passage 3 to 5 were plated at 5000 cells per well in 12-well 
plates, grown until 80 to 90% confluent, and then transduced with 
and without an AdOPG and RFP in DMEM at a MOI of 200 and 
polybrene (4 g/ml; Sigma-Aldrich, St. Louis, MO). Twenty-four hours 
after transduction, hMSCs were subjected to differentiation medium 
consisting of proliferation medium plus 10 mM -glycerophosphate, 
ascorbic acid (50 g/ml), and 0.1 M dexamethasone. Cell cultures 
were evaluated on day 7 after transduction for morphological changes, 
transduction efficiency, and Western blot.
Osteogenic differentiation of hMSCs on Col-GAG and MC-GAG
hMSCs (3 × 105) were seeded onto 8-mm discs of CG-GAG and 
MC-GAG scaffolds in proliferation medium. The cells were resus-
pended in growth medium, and half of the suspension was used to 
seed one side of the scaffold. After incubation for 15 min, the scaffold 
was turned upside down and the other half of the suspension was 
used to seed the opposite side. One millimeter of growth medium was 
then added to each well. Twenty-four hours after seeding, the medi-
um was switched to osteogenic differentiation medium consisting of 
10 mM -glycerophosphate, ascorbic acid (50 g/ml), and 0.1 M 
dexamethasone.
Indirect hMSC and hOC cocultures
hMSCs (2 × 105) were seeded to 6 mm of Col-GAG and MC-GAG 
scaffolds in proliferation medium. Twenty-four hours after seeding 
hMSCs, primary hOC precursors (6 × 104; Lonza Inc., Allendale, NJ) were 
cultured in Osteoclast Precursor Basal Medium (Lonza, Allendale NJ) 
supplemented with M-CSF (33 ng/ml), RANKL (66 ng/ml), 10 mM 
-glycerophosphate, ascorbic acid (50 g/ml), and 0.1 M dexa-
methasone for concurrent hMSC and hOC differentiation on 24-well 
Corning Osteo Assay Surface Microplates (Corning, NY). After 2 hours, 
Col-GAG and MC-GAG scaffolds were transferred to 8-m Transwell 
inserts (Corning, NY) and cocultured with hOCs. Medium was changed 
every 3 days for 3 weeks.
Direct hMSC and hOC cocultures
hMSCs (3.5 × 105) were seeded to 8 mm of Col-GAG and MC-GAG 
scaffolds in proliferation medium. Twenty-four hours after seeding 
hMSCs, hOCs (6 × 104) were cultured in Osteoclast Precursor Basal 
Medium (Lonza Inc., Allendale NJ) supplemented with M-CSF 
(33 ng/ml), RANKL (66 ng/ml), 10 mM -glycerophosphate, ascorbic 
acid (50 g/ml), and 0.1 M dexamethasone on 24-well Osteo Assay 
Microplates. After 2 hours, Col-GAG and MC-GAG scaffolds were 
transferred to the Osteo Assay Microplates and directly cocultured 
with hOCs. Medium was changed every 3 days for 2 weeks.
Quantitative real-time reverse transcription polymerase 
chain reaction
RNeasy kit (Qiagen, Valencia, CA) was used to extract total RNA 
from scaffolds at 0, 3, and 14 days of culture. Gene sequences for 
18S, Runx2, OPN, OPG, and receptor activator of RANKL were ob-
tained from the National Center for Biotechnology Information 
gene database, and primers were designed (table S1). qRT-PCR was 
performed on the Opticon Continuous Fluorescence System (Bio-
Rad Laboratories Inc., Hercules, CA) using the QuantiTect SYBR 
Green RT-PCR Kit (Qiagen). Cycle conditions were as follows: re-
verse transcription at 50°C (30 min); activation of HotStarTaq DNA 
polymerase/inactivation of reverse transcriptase at 95°C (15 min); 
and 45 cycles of 94°, 58°, and 72°C for 15, 30, and 45 s, respectively. 
Results were analyzed and presented as representative graphs of 
triplicate experiments.
Enzyme-linked immunosorbent assay
Supernatants were collected from hMSC only, osteoclast (OC) only, or 
hMSC and hOC cocultures. OPG protein concentrations were de-
termined using the Human OPG DuoSet ELISA Kit (R&D Systems, 
Minneapolis, MN) according to the manufacturer’s instructions. 
Briefly, a 96-well microplate was coated with the capture antibody 
and incubated overnight at room temperature. After blocking, sam-
ples were incubated for 2 hours at room temperature with the detec-
tion antibody, followed by incubation with streptavidin-horseradish 
peroxidase (HRP) for 20 min. The reaction was quenched by adding 
100 l of 2 N H2SO4. Plates were read at 450- and 540-nm wave-
lengths on the Epoch Microplate Reader (BioTex, Winooski, VT).
CT imaging
Scaffolds were fixed using 10% formalin, and mineralization was 
quantified by CT imaging using Scanco 35 (Scanco Medical AG, 
Bruttisellen, Switzerland) in triplicate for each time point. Scans were 
performed at medium resolution with a source voltage E of 70 kVp 
and with a current I of 114 A. The images had a final element size 
of 12.5 m. Images were analyzed using software supplied from 
Scanco (Image Processing Language version 5.6) and reconstructed 
into 3D volumes of interest. Optimum arbitrary threshold values of 
20 (containing scaffold and mineralization) and 80 (containing 
mineralization alone) were used uniformly for all specimens to 
quantify mineralized areas from surrounding unmineralized scaf-
fold. Analysis of 3D reconstructions was performed using Scanco 
Evaluation script no. 2 (3D segmentation of two volumes of interest: 
solid dense in transparent low-density object) and script no. 6 (bone 
volume/density-only bone evaluation) for volume determinations.
Western blot
Total protein lysates were prepared from scaffolds at 0, 3, 14, 28, 42, 
and 56 days of culture by incubating scaffolds morselized using scissors 
in 3× SDS reducing sample buffer. Lysates were then incubated at 
95°C for 5 min and centrifuged in 0.2 m of Spin-X filters (Corning 
Costar, Corning, NY) at 14,000 rpm for 5 min. Protein concentra-
tion was measured, and equal amounts were subjected to 4 to 20% 
SDS–polyacrylamide gel electrophoresis (Bio-Rad, Hercules, CA). 
Western blot analysis was carried out with antibodies against OPG, 
RANKL, p-Smad1/5, total Smad5, p-ERK1/2, total ERK1/2, and 
-actin, followed by 1:4000 dilutions of HRP-conjugated immuno-
globulin G antibodies (Bio-Rad, Hercules, CA) and an enhanced 
chemiluminescent substrate (Thermo Fisher Scientific, Rockford, IL). 
For the detection of p-Smad1/5 and total Smad5, 10 g of lysate was 
loaded per lane. For the detection of OPG, RANKL, p-ERK1/2, total 
ERK1/2, and -actin, 20 g of lysate was loaded per lane. All anti-
bodies were obtained from Cell Signaling Technology (Danvers, MA), 
with the exception of RANKL, OPG, and -actin antibodies from 
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Santa Cruz Biotechnology (Santa Cruz, CA). Imaging analysis was 
carried out using ImageJ (NIH, Bethesda, MD). The RANKL/
OPG-relative protein ratios were calculated by quantifying the den-
sitometry of all RANKL and OPG normalized to actin using ImageJ 
(NIH, Bethesda, MA).
WST-1 assay
Culture medium was supplemented with cell proliferation reagent 
WST-1 (Roche, Basel, Switzerland) at a 1:10 concentration. Scaffolds 
were incubated for 3 to 4 hours at 37°C in a humidified atmosphere 
with 5% CO2. Absorbance of the incubation medium was measured 
at 450 and 690 nm (Epoch spectrophotometer, BioTek, Winooski, VT).
TRAP staining
hOCs were detected using the Leukocyte TRAP Kit 387-A (Sigma- 
Aldrich) according to the manufacturer’s instructions. Briefly, cultured 
cells were fixed with formaldehyde for 5 min at room temperature, 
washed, and air-dried. After staining, TRAP-positive multinucleated 
cells were observed under a phase-contrast microscope at 20× mag-
nification and digitally photographed.
Resorption pit assay
Activity of hOCs in single culture or cocultured with scaffolds with 
and without hMSCs was evaluated for resorption pit formation on 
Osteo Assay Microplates. At the completion of the culture period, 
culture medium was aspirated, and 500 l of 10% bleach solution 
was added for 5 min at room temperature. The wells were washed with 
distilled water and allowed to dry at room temperature for 3 to 5 hours. 
Pits were observed using a standard microscope and digitally pho-
tographed. The percentage of resorption for the whole well of the 
culture at magnification 2× was calculated by ImageJ.
Statistical analysis
All statistical analyses were performed using SPSS version 24 
(Chicago, IL). Data points were composed of duplicates of at least 
three independent experiments, unless otherwise indicated. Mean 
measurements of mRNA expression were analyzed for statistical 
significance by ANOVA, followed by post hoc tests using the Tukey’s 
criterion. A value of P < 0.05 was considered significant.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/5/6/eaaw4991/DC1
Supplementary Materials and Methods
Table S1. Primer sequences.
Fig. S1. Osteoclasts migrate into Col-GAG and MC-GAG scaffolds in the presence of control 
hMSCs in direct cocultures.
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